Tag Archives | broccoli

Superbroccoli.info – the facts about broccoli in new website

Beneforté superbroccoli has been conventionally bred to contain 2-3 times the levels of naturally occurring compound called glucoraphanin, and has been developed by British science at the Institute of Food Research and the John Innes Centre.  Research suggests this could help to maintain cardiovascular health and to reduce the risk of some forms of cancer. www.superbroccoli.info presents [...]

Read full story

Eating broccoli retunes metabolism

Researchers at the Institute of Food Research have obtained the first evidence from human studies of how diets rich in glucosinolates, such as glucoraphanin found in broccoli, can ‘re-tune’ cellular processes that get disrupted as we age. Retuning these processes to normal may contribute to the reduced risk of cancer seen in people who eat [...]

Read full story

Reliably higher levels of healthy compound in Beneforté broccoli

Field trials and genetic studies have shown that a new variety of broccoli reliably yields higher levels of a health-promoting compound. Broccoli contains a compound called glucoraphanin, which has been shown to promote health by maintaining cardiovascular health and a reduction in the risk of cancer. A long term breeding programme to increase glucoraphanin levels [...]

Read full story

IFR supporting NutraFormulate Conference

IFR is pleased to support NutraFormulate – Ingredients for Healthy Living, which will be held at the NMM Exhibition Centre, Birmingham, 20-21  March 2013. Richard Mithen and Paul Kroon from the Institute of Food Research will be speaking at NutraFormulate – Ingredients for Healthy Living Food for Thought Conference in March 2013. The Food & Health [...]

Read full story

Major award to study protective effects of broccoli consumption against prostate cancer

The Prostate Cancer Foundation is providing $1M of funding to the Institute of Food Research and the University of East Anglia (UEA) to study the protective effects of broccoli consumption against prostate cancer. It builds upon several years of research led by Professor Richard Mithen on the biological activity of a naturally occurring compound called [...]

Read full story